Immunoassays sind diagnostische Analysemethoden, die Antikörper oder Antigene verwenden, um Marker oder Analyten in biologischen Matrizen mit hoher Sensitivität/Spezifität zu erkennen.
Die ... Lesen Sie mehr
Immunoassays sind diagnostische Analysemethoden, die Antikörper oder Antigene verwenden, um Marker oder Analyten in biologischen Matrizen mit hoher Sensitivität/Spezifität zu erkennen.
Die spezifische Bindung von Antikörpern an biologische Ziele macht sie zu effizienten Methoden für den Nachweis von Krankheitsindikatoren. Bei Bioactiva gibt es verschiedene Immunoassays, die auf unterschiedlichen Designs und Detektionsmechanismen basieren. Schauen Sie sich unseren Bioactiva-Katalog an, um den Immunoassay zu finden, der am besten zu Ihren Laboranforderungen passt.
AMA-M2-G is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).
Borrelia-G is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against Borrelia burgdorferi.
The assay is a tool in the diagnosis of Lyme borreliosis.
Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi.
The assay is a tool in the diagnosis of Lyme borreliosis.
Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.
Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.
COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.
The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.
The M30 CytoDeath™ ELISA offers a unique possibility to measure human cell death by apoptosis in cell cultures, multicellular spheroids and organ culture systems. The M30 CytoDeath™ ELISA is a product developed for cell culture applications, with a dynamic range and sensitivity suitable for in vitro work, making it a useful drug screening tool.